Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,102 | 503 | 87.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,110 | 1 | 8.8% |
| Education | $460.02 | 12 | 3.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $1,501 | 20 | $0 (2024) |
| Janssen Biotech, Inc. | $1,099 | 56 | $0 (2024) |
| Teleflex LLC | $738.51 | 12 | $0 (2024) |
| Astellas Pharma US Inc | $731.89 | 29 | $0 (2023) |
| Sumitomo Pharma America, Inc. | $698.19 | 19 | $0 (2024) |
| PROCEPT BioRobotics Corporation | $621.36 | 8 | $0 (2024) |
| ABBVIE INC. | $574.32 | 34 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $553.87 | 27 | $0 (2024) |
| Dendreon Pharmaceuticals LLC | $510.51 | 23 | $0 (2024) |
| NeoTract Inc. | $462.23 | 12 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,025 | 65 | PFIZER INC. ($1,129) |
| 2023 | $2,506 | 86 | Sumitomo Pharma America, Inc. ($271.93) |
| 2022 | $1,357 | 69 | Myovant Sciences Inc. ($196.55) |
| 2021 | $1,562 | 59 | Myovant Sciences Inc. ($204.08) |
| 2020 | $423.55 | 18 | NeoTract Inc. ($121.82) |
| 2019 | $1,359 | 70 | NeoTract Inc. ($184.00) |
| 2018 | $1,125 | 63 | Bayer HealthCare Pharmaceuticals Inc. ($203.06) |
| 2017 | $1,313 | 86 | Astellas Pharma US Inc ($155.42) |
All Payment Transactions
516 individual payment records from CMS Open Payments — Page 1 of 21
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $17.80 | General |
| Category: UROLOGY | ||||||
| 12/18/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $20.07 | General |
| Category: HORMONE THERAPY | ||||||
| 12/17/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $118.71 | General |
| Category: ONCOLOGY | ||||||
| 12/12/2024 | COLOPLAST CORP | Luja Coude (Device) | Food and Beverage | In-kind items and services | $24.85 | General |
| Category: Continence Care | ||||||
| 12/12/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $19.07 | General |
| Category: Oncology | ||||||
| 11/26/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/26/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $1.63 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/25/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $19.66 | General |
| Category: ONCOLOGY | ||||||
| 11/25/2024 | CIVCO Medical Instruments | — | Food and Beverage | Cash or cash equivalent | $15.16 | General |
| 11/21/2024 | Cumberland Pharmaceuticals, Inc. | CALDOLOR (Drug) | Food and Beverage | In-kind items and services | $20.90 | General |
| Category: ANESTHESIOLOGY PAIN MANAGEMENT | ||||||
| 11/20/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $22.44 | General |
| Category: ONCOLOGY | ||||||
| 11/07/2024 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $23.54 | General |
| 11/06/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $18.81 | General |
| Category: ONCOLOGY | ||||||
| 10/29/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: HORMONE THERAPY | ||||||
| 10/25/2024 | Calyxo, Inc. | CVAC ASPIRATION SYSTEM (Device) | Food and Beverage | In-kind items and services | $34.59 | General |
| Category: Urology | ||||||
| 10/24/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $17.51 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/23/2024 | PROCEPT BioRobotics Corporation | AQUABEAM SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $111.18 | General |
| Category: UROLOGY | ||||||
| 10/23/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $26.23 | General |
| Category: UROLOGY | ||||||
| 10/21/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $17.56 | General |
| Category: Oncology | ||||||
| 10/03/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: Oncology | ||||||
| 09/27/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $19.42 | General |
| Category: UROTHELIAL CANCER | ||||||
| 09/24/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $22.68 | General |
| Category: HORMONE THERAPY | ||||||
| 09/13/2024 | 180 Medical, Inc. | — | Food and Beverage | In-kind items and services | $14.79 | General |
| 09/11/2024 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $49.36 | General |
| Category: INTERVENTIONAL UROLOGY | ||||||
| 08/28/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $16.30 | General |
| Category: HORMONE THERAPY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 48 | 7,453 | 40,043 | $2.6M | $652,017 |
| 2022 | 49 | 6,277 | 26,683 | $2.2M | $513,218 |
| 2021 | 58 | 7,572 | 36,115 | $2.9M | $773,851 |
| 2020 | 63 | 9,035 | 67,218 | $3.4M | $859,780 |
All Medicare Procedures & Services
218 procedure records from CMS Medicare Utilization — Page 1 of 9
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 977 | 1,613 | $711,663 | $180,005 | 25.3% |
| J1952 | Leuprolide injectable, camcevi, 1 mg | Office | 2023 | 25 | 1,344 | $385,620 | $88,711 | 23.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 516 | 686 | $214,756 | $54,540 | 25.4% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 104 | 148 | $145,511 | $34,102 | 23.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 150 | 188 | $115,941 | $30,014 | 25.9% |
| 51728 | Complex measurement of pressure of urine flow in bladder with voiding pressure studies | Office | 2023 | 72 | 72 | $93,977 | $24,058 | 25.6% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 735 | 1,076 | $59,363 | $19,372 | 32.6% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 25 | 117 | $88,656 | $16,243 | 18.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 109 | 109 | $63,065 | $15,342 | 24.3% |
| 55700 | Biopsy of prostate gland | Office | 2023 | 62 | 65 | $64,953 | $14,800 | 22.8% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 179 | 304 | $52,312 | $14,343 | 27.4% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 97 | 101 | $50,001 | $13,269 | 26.5% |
| 0421T | Waterjet destruction of prostrate accessed through the urethra | Facility | 2023 | 17 | 17 | $47,948 | $12,824 | 26.7% |
| J9155 | Injection, degarelix, 1 mg | Office | 2023 | 13 | 3,600 | $39,960 | $11,609 | 29.1% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 670 | 1,039 | $49,921 | $10,500 | 21.0% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 123 | 128 | $37,125 | $10,179 | 27.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 809 | 1,209 | $10,881 | $10,097 | 92.8% |
| 52356 | Crushing of stone of ureter with insertion of stent using an endoscope | Facility | 2023 | 23 | 24 | $34,443 | $9,442 | 27.4% |
| 52310 | Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | Office | 2023 | 24 | 24 | $30,706 | $7,507 | 24.4% |
| 52601 | Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | Facility | 2023 | 12 | 12 | $30,546 | $7,476 | 24.5% |
| 52235 | Destruction and/or removal of growth of bladder and urethra using an endoscope, 2.0-5.0 cm | Facility | 2023 | 20 | 22 | $21,969 | $6,022 | 27.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 31 | 31 | $23,661 | $5,701 | 24.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 46 | 46 | $20,537 | $5,630 | 27.4% |
| 51797 | Insertion of device into abdomen with pressure and urine flow rate study | Office | 2023 | 30 | 30 | $20,733 | $5,346 | 25.8% |
| 55899 | Other procedure on male genital system | Office | 2023 | 19 | 19 | $24,800 | $5,099 | 20.6% |
About Dr. Gary Goldberg, MD
Dr. Gary Goldberg, MD is a Urology healthcare provider based in Manhasset, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1790764736.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gary Goldberg, MD has received a total of $12,672 in payments from pharmaceutical and medical device companies, with $3,025 received in 2024. These payments were reported across 516 transactions from 63 companies. The most common payment nature is "Food and Beverage" ($11,102).
As a Medicare-enrolled provider, Goldberg has provided services to 30,337 Medicare beneficiaries, totaling 170,059 services with total Medicare billing of $2.8M. Data is available for 4 years (2020–2023), covering 218 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location Manhasset, NY
- Active Since 01/10/2006
- Last Updated 08/05/2013
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1790764736
Products in Payments
- ORGOVYX (Drug) $998.17
- XTANDI (Drug) $575.33
- UROLIFT (Device) $569.37
- ERLEADA (Drug) $536.60
- PROVENGE (Drug) $527.65
- BOTOX (Biological) $491.15
- Xofigo (Drug) $430.95
- AQUABEAM ROBOTIC SYSTEM (Device) $383.08
- NOCDURNA (Drug) $359.97
- Erleada (Drug) $320.31
- UroLift System (Device) $304.46
- ZYTIGA (Drug) $266.38
- ELIGARD (Drug) $262.77
- AQUABEAM SYSTEM (Device) $238.28
- UroLift (Device) $227.61
- XIAFLEX (Biological) $193.08
- MYRBETRIQ (Drug) $189.10
- GEMTESA (Drug) $186.02
- FIRMAGON (Drug) $184.04
- AVEED (Biological) $179.52
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Manhasset
Dr. Ilan Safir, M.d, M.D
Urology — Payments: $15,763
Dr. Sherman Chan, Md, MD
Urology — Payments: $10,534
Richard Maiman, Md, MD
Urology — Payments: $7,461
Dr. Raymond Sultan, M.d, M.D
Urology — Payments: $5,164
Dr. Dimitri Kessaris, Md, MD
Urology — Payments: $4,531
Dr. Sarah Girardi, Md, MD
Urology — Payments: $3,362